Disease Info Card

Lymphoma

Information about Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lymphoma

Most recent studies have shown that Lymphoma shares some biological mechanisms with acute-lymphocytic-leukemia, b-cell-lymphomas, burkitt-lymphoma, carcinoma, chronic-lymphocytic-leukemia, diffuse-large-b-cell-lymphoma, hodgkin-disease, leukemia, lymphoid-leukemia, lymphoma-follicular, lymphoma-non-hodgkin, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, multiple-myeloma, neoplasm-metastasis, neoplasms, sarcoma, skin-neoplasms, t-cell-lymphoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphoma, and have been seen in publications frequently: Angiogenesis, Cell Activation, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Dna Repair, Drug Resistance, Hypersensitivity, Immune Response, Induction Of Apoptosis, Interphase, Localization, Methylation, Oncogenesis, Pathogenesis, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Lymphoma, such as BCL2, BCL6, CD4, CD5, CD8A, CTLA4, DDIT3, HLA-DQA1, IL2, KRT20, MID1, MME, MS4A1, MYC, NOD2, PTPRC, TNF, TNFRSF8, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Lymphoma Related Genes

click to see detail information for each gene

BCL2 BCL6 CD4
CD5 CD8A CTLA4
DDIT3 HLA-DQA1 IL2
KRT20 MID1 MME
MS4A1 MYC NOD2
PTPRC TNF TNFRSF8
TP53